Medable, Inc., helps scientific writers maximize their efficiency and accuracy by generating reports and insights.
Medable, Inc., leading technology provider for modern clinical trials, is using a new intelligent automation technology to provide faster build of standard trial timelines. Medable saves time and removes electronic clinical outcomes assessment (eCOA) from the critical path to trial go-live.
Medable’s updated eCOA includes an auto-configuration tool that produces standard configurations, such as schedules of assessments, anchor dates, and patient flags, in minutes. Medable’s auto-validate tool also eliminates weeks of tedious testing to automatically deliver a downloadable Configuration Validation Report (CVR) that validates the quality of study builds.
“We are reimagining the way clinical trials are deployed by eliminating many of the biggest process bottlenecks,” stated Michelle Longmire, CEO and co-founder of Medable. “Starting with eCOA, we are accelerating clinical trials while helping to improve data quality – ultimately enabling our vision of a one-day study start-up to help deliver effective treatments and cures to patients faster. In 2024, expect to see more innovative technologies and new ways of delivering streamlined, patient- centric trials from Medable.”
Rare Patient Voice, LLC Awards Over $13 million Dollars Over a Decade in Business
Rare Patient Voice, LLC (RPC) empowers patients and family caregivers with opportunities to participate in all types of research including market research, health economics outcomes and real-world evidence, user experience/human factors studies, and clinical trials. RPC connects rare and non-rare disease patients and their loved ones with decision-makers and compensates participants for their opinions and insights. This year, RPC announced that they had given patients and caregivers over $13 million dollars since the company was founded in 2013.
“The mission of Rare Patient Voice has been to empower patients and family caregivers to share their voices,” said Wes Michael, Founder and President of Rare Patient Voice, in a statement. “We now have over 145,000 RPV community members, across nine countries. For 2024, we look forward to continuing to connect patients and family caregivers with study opportunities in which they can share their insights and experiences with researchers and companies.”
Inizio Evoke Simplifies Connected Solutions for Clients
Evoke, an Inizio company, has simplified its brand and enhanced its offerings to ensure clients receive the most effective solutions tailored to the dynamic healthcare landscape. The platform unites its specialty agencies and capabilities under a singular Inizio Evoke brand and core service areas in Marketing, Comms, Transformation, Media, and Access. The brand is further connecting global capabilities to deliver the best thinking and provide clients with best-in-industry work, creative, and innovative solutions.
“Under the banner of our bold new Inizio Evoke brand, we are better equipped to tap into Inizio’s global powerhouse as a leader in the pharma and life sciences industry, providing seamless access to the full Inizio platform and expertise across Advisory, Medical, Engage, and Biotech. This ensures our clients have access to the latest cutting-edge solutions along with a partner that is fully invested in their success.” said Reid Connolly, CEO of Inizio Evoke.
Evoke specialty agencies are now operating under the new Inizio Evoke brand as follows: Inizio Evoke, Inizio Evoke Drive, Inizio Evoke Comms, Inizio Evoke Transformation, Inizio Evoke Access, and Inizio Evoke Media.
The new Inizio Evoke brand will continue to serve as a premier partner for the world’s most innovative and ambitious healthcare organizations, with an even stronger focus on delivering client-centric solutions that drive transformative growth.
